An Effective and Safe Novel Treatment of Opioid Use Disorder: Unilateral Transcranial Photobiomodulation.

Front Psychiatry · 2021 · PMC8382852 · PMID 34447323

Europe PMC DOI

hedged sentences

0.0001

closest p · 0.0× alpha

0.0750

boldest claim

The sentences

highly significantp < 0.0001actually significant

Results: Our primary outcome was changes in pre-treatment opioid craving scale (OCS) minus baseline, and we found using a mixed model that the active group had a highly significant treatment * time benefit over the sham group, p < 0.0001, effect size at the last follow-up of 1.5.

also in 132,142 other papers

fell short of significancep = 0.075so close (0.05 < p ≤ 0.1)

Mixed model analysis of the HARS indicated that there were no significant main or interactive effects of Site or suboxone and the visit:treatment interaction fell short of significance [ F (11, 314) = 1.69, p = 0.075].

also in 361 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.